Strong Gross Margins Of Almost 77% Help Drive Can B Corp.’s (OTCQB: CANB) Marco Alfonsi’s, CEO, Optimism About The Company’s Financial Performance As Hemp-Derived CBD Products Soar

One of the reasons that Marco Alfonsi, CEO, is so optimistic about the future financial performance of Can B Corp. (OTCQB: CANB) are the strong gross margins of almost 77% the CBD company has achieved. In a report by site Bloomberg on CAN B Corp.’s (OTCQB: CANB) Q2 2020 financial results, the company reported in the three month period ended June 30, 2020 that its gross profits rose 24% to 77% in 2020 from 53% in the comparable period in 2019.

The CBD market has drawn intense interest from media companies. stockmarketpress.com features specialized coverage of related stocks such as Can B Corp. (OTCQB: CANB), Aurora Cannabis Inc. (NYSE:ACB) (TSX: ACB), Cronos Group (NASDAQ: CRON), Canopy Growth Corp. (NYSE: CGC), Charlotte’s Web (CSE: CWEB), INSYS Therapeutics, Inc. (NASDAQ: INSY), cbdMD (NYSE: YCBD), Joy Organics (NASDAQ: JOYG),, GW Pharmaceuticals (NASDAQ: GWPH) and Supreme Cannabis Co. (OTC: SPRWF).

Strong Gross Margins Of Almost 77% Help Drive Can B Corp.’s (OTCQB: CANB) Marco Alfonsi, CEO, Optimism About The Company’s Financial Performance As Hemp-Derived CBD Products Soar

Marco Alfonsi, CEO of  Can B Corp. (OTCQB: CANB), said, “We remain enthusiastic about our business prospects and returning to growth mode. Given our strong gross margins of almost 77%, we feel confident in being able to return to the position we were earlier in 2020 when our revenue growth outpaced in growth in expenses, as we achieved operating efficiencies.”

In addition to the growth in gross profit or margins to 77% in its most recent quarterly report, Can B Corp. (OTCQB: CANB) documented its successful effort to cut expenses: cut by 52% all consulting costs by $220,721; reimbursable expenses dropped by $14,800 or 43% compared to the same period the prior year; a 19% drop in other operating expenses of $46,774. The result was a 17% drop in net loss by $249,066.

Gross Margins Rise To 76.6%

The impact of COVID-19 contributed to the company’s 68% decline in revenue for the 2020 period, the company said. However, due to the cost cuts, Can B Corp. (OTCQB: CANB) was able to achieve a gross margin of 76.6% compared to 52.8% in the comparable period in 2019. Detailed in the Q2 2020 financial results reported by Bloomberg was the company’s 17% reduction of its net loss by $249,066. Strong Gross Margins Of Almost 77% Help Drive Can B Corp.’s (OTCQB: CANB) Marco Alfonsi’s, CEO, Optimism About The Company’s Financial Performance As Hemp-Derived CBD Products Soar.

A Projection Of $30 Billion By 2023 For CBD Industry

Can B Corp. (OTCQB: CANB) is active in a CBD industry seen as hitting $30 billion at retail by 2023, according to a projection by Marijuana Business Daily. The diverse marketing strategy and multi-channel branding for the health and wellness emerging growth company. At Can B Corp. (OTCQB: CANB), a broad assortment of hemp-derived CBD lines have optimistic futures because of the company’s diverse marketing strategies: proprietary licensed brands, white labels, private labels through third parties and distribution through various channels such as retail, professional (physician), direct sales through its website and sales through subsidiaries. This health and wellness firm is an emerging growth company.

A Health And Wellness Emerging Growth Company

Can B Corp. (OTCQB: CANB) offers an extensive line of drops/tinctures, oils, creams, moisturizers, chews, isolate, gel caps, concentrates and more. Its diverse proprietary product lines are available under license, private label and branded labels. This health and wellness emerging growth company offers lines of hemp derived CBD, CBD and non-CBD under license for the Lifeguard® lifestyle brand, Canbiola branded through physicians, products through white label and private label plus other subsidiaries. Strong Gross Margins Of Almost 77% Help Drive Can B Corp.’s (OTCQB: CANB) Marco Alfonsi’s, CEO, Optimism About The Company’s Financial Performance As Hemp-Derived CBD Products Soar.

Can B Corp. (OTCQB: CANB) Offers An Extensive Line Of CBD Products

Can B Corp. (OTCQB: CANB) is a health and wellness company providing CBD products under the brands Canbiola, Seven Chakras, NuWellness, Pure Leaf Oil and Duramed. It markets to multi-channels including medical offices, doctor’s offices, retailers, online and direct. Strong Gross Margins Of Almost 77% Help Drive Can B Corp.’s (OTCQB: CANB) Marco Alfonsi, CEO, Optimism About The Company’s Financial Performance As Hemp-Derived CBD Products Soar.

Source: Stock Market Press

Join Stock Market Press’ newsletter for the latest in IPO, market commentary and company profiles.

Stock Market Press is a financial news company that delivers up to date stock news, introduces private and public companies to a wide audience of investors, consumers, journalists and the general public via social media and a rapidly expanding network.

Contact:

Stock Market Press
110 Wall St.
New York, NY 10005 info@stockmarketpress.com Safe Harbor Statement:

Statements in this news release may be ”forward-looking statements.” Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions or any other statements relating to our future activities or other future events or conditions. These statements are based on current expectations, estimates and projections about our business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and are likely to, differ materially from what is expressed or forecasted in forward-looking statements due to numerous factors. Any forward-looking statements speak only as of the date of this news release and Stock Market Press undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date of this news release.

See Stock Market Press disclaimer: https://stockmarketpress.com/disclaimer/ SOURCE: Stock Market Press